0
0
Read Time:12 Second
Gland Pharma Limited has informed the Exchange regarding a press release dated August 26, 2025, titled “Gland Pharma receives approval from the United States Food and Drug Administration (USFDA) for Vasopressin 5% Dextrose Injection USP (RTU vial)”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %